Navigation Links
MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014

WILMINGTON, Delaware, November 3 /PRNewswire/ -- The new market research report, 'Global Stem Cell and Advanced Technologies Market' (2009 - 2014)', published by MarketsandMarkets ( analyzes the major trends in the global stem cell market. It identifies and analyzes the main market drivers, restraints, and opportunities for the various products, services, technologies, and applications submarkets in different geographic regions.

Browse in-depth TOC on stem cell market. Early buyers will receive 10% customization of report.


(Due to the length of this URL, it may be necessary to copy and paste the hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.

The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.

    Market Estimates and Forecasts

    The report categorizes the global stem cell market as follows:

    - Stem Cell Products (adult stem cell, human embryonic stem cell, and
      other stem cell types)

    - Stem Cell Services (stem cell banking, stem cell acquisition and
      testing, drug discovery and target identification,
      isolation/characterization services, and molecular biology )

    - Stem Cell Technologies (stem cell acquisition, stem cell production,
      cryopreservation, and expansion and subculture)

    - Stem Cell Applications (regenerative medicine - neurological disorders,
      orthopedics, cancer, hematological disorders, myocardial infarction
      and cardiovascular diseases, injuries, diabetes, liver disorder,
      incontinence, and drug development)

Analyst Briefing Presentation on the Global Stem Cells Market to be held on 18th November, 2009

The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global Stem Cells Market to be held on 18th November, 2009.

To register your participation, please click here

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 40 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at

    Ms. Sunita
    108, West 13th Street,
    DE, 19801
    County of New Castle
    Tel: +1-888-989-8004

SOURCE Markets and Markets

SOURCE Markets and Markets
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Marketsandmarkets: Global Minimally Invasive/ Non Invasive Market Worth $24.4 Billion by 2014
2. MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014
3. MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014
4. Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
5. Public-Private Partnerships Key to Achieving Global Food Security, Says DuPont Leader
6. Reportlinker Adds Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis
7. Global Med Technologies(R), Inc. Licenses EdgeLab to Seven Laboratories at University Hospital of Reims, France
8. Global Bioenergies is Setting-Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Renewable Resources
9. Systagenix Announces Formation of New Global Medical Advisory Board to Support Future Clinical Advances in Wound Care
10. Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac
11. Biotechnology Can Address Global Mega Trends, DuPont Leader Says
Post Your Comments:
(Date:11/30/2015)... -- Champions Oncology, Inc. (CSBR), engaged in the development of ... and use of oncology drugs, today announced that ... at the LD MICRO Investor Conference on Wednesday, December ... conference, held at the Luxe Sunset Bel Air Hotel ... feature 200 small/micro-cap companies and is expected to host ...
(Date:11/30/2015)...  HUYA Bioscience International, the leader in accelerating global ... today announced it has signed a Memorandum of Understanding ... collaboration between KDDF and HUYA with the ultimate goal ... for the global market. China,s ... innovative preclinical and clinical stage compounds. The company advances ...
(Date:11/30/2015)... Germany , November 30, 2015 ... Vienna, Austria to be held December 1-4, ... in Vienna, Austria to be ... owned subsidiary of Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), announced ... Therapy Suite at the 3rd European Congress of NeuroRehabilitation ...
(Date:11/30/2015)... and PETACH TIKVAH, Israel , Nov. 30, ... BCLI ), a leading developer of adult stem cell technologies ... Cell Therapeutics Ltd., has been awarded an additional grant of ... the Chief Scientist (OCS). This grant, the second this year, ... activities to approximately $1.8 million (approximately NIS7 million).  ...
Breaking Biology Technology:
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/11/2015)... 2015   MedNet Solutions , an innovative SaaS-based eClinical ... is pleased to announce that it will be a Sponsor ... event, to be held November 17-19 in Hamburg ... demonstrations of iMedNet , MedNet,s easy-to-use, proven ... has been able to deliver time and cost savings ...
Breaking Biology News(10 mins):